These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 441097)

  • 1. Opiate modification of intracranial self-stimulation in the rat.
    Weibel SL; Wolf HH
    Pharmacol Biochem Behav; 1979 Jan; 10(1):71-8. PubMed ID: 441097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naltrexone maintenance fails to alter amphetamine effects on intracranial self-stimulation in rats.
    Sakloth F; Negus SS
    Exp Clin Psychopharmacol; 2018 Apr; 26(2):195-204. PubMed ID: 29528663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facilitation of self-stimulation behavior following intracerebral microinjections of opioids into the ventral tegmental area.
    Broekkamp CL; Phillips AG
    Pharmacol Biochem Behav; 1979 Sep; 11(3):289-95. PubMed ID: 504308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of opiate receptors in the potentiation of pentobarbital sleeping time by the acute and chronic administration of opiates.
    Pechnick RN; Terman GW
    Neuropharmacology; 1987 Nov; 26(11):1589-93. PubMed ID: 2829049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Acute and Repeated Administration of Oxycodone and Naloxone-Precipitated Withdrawal on Intracranial Self-Stimulation in Rats.
    Wiebelhaus JM; Walentiny DM; Beardsley PM
    J Pharmacol Exp Ther; 2016 Jan; 356(1):43-52. PubMed ID: 26491062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-administration of D-Ala2-Met-enkephalinamide at hypothalamic self-stimulation sites.
    Olds ME; Williams KN
    Brain Res; 1980 Jul; 194(1):155-70. PubMed ID: 7378834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of the development of acute opiate tolerance by increased dopamine receptor sensitivity.
    Martin JR; Takemori AE
    J Pharmacol Exp Ther; 1987 Apr; 241(1):48-55. PubMed ID: 3572795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opiates and thermoregulation in mice. IV. Tolerance and cross-tolerance.
    Rosow CE; Miller JM; Poulsen-Burke J; Cochin J
    J Pharmacol Exp Ther; 1982 Dec; 223(3):702-8. PubMed ID: 7143233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of pentazocine and other opiates on shock detection in the rat: involvement of opiate and dopamine receptors.
    Hernández LL; Appel JB
    Psychopharmacology (Berl); 1980 Feb; 67(2):155-63. PubMed ID: 6245423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminative stimulus effects of acute morphine followed by naltrexone in the squirrel monkey.
    White DA; Holtzman SG
    Psychopharmacology (Berl); 2003 May; 167(2):203-10. PubMed ID: 12644889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal separation alters ICSS responding in adult male and female rats, but morphine and naltrexone have little affect on that behavior.
    Michaels CC; Easterling KW; Holtzman SG
    Brain Res Bull; 2007 Jul; 73(4-6):310-8. PubMed ID: 17562397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose- and time-dependent effects of narcotic analgesics on intracranial self-stimulation in the rat.
    Schaefer GJ; Holtzman SG
    Psychopharmacology (Berl); 1977 Aug; 53(3):227-34. PubMed ID: 19804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracranial self-stimulation in rats: sensitization to an opioid antagonist following acute or chronic treatment with mu opioid agonists.
    Easterling KW; Holtzman SG
    J Pharmacol Exp Ther; 1997 Apr; 281(1):188-99. PubMed ID: 9103497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereoselective effects of opiate agonists and antagonists on ingestive behavior in rats.
    Lowy MT; Starkey C; Yim GK
    Pharmacol Biochem Behav; 1981 Oct; 15(4):591-6. PubMed ID: 7291263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opiate agonist-antagonist interactions: application of a three-key drug discrimination procedure.
    France CP; Woods JH
    J Pharmacol Exp Ther; 1985 Jul; 234(1):81-9. PubMed ID: 4009506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral effects of morphine, levorphanol, dextrorphan and naloxone in the frog Rana pipiens.
    Pezalla PD; Stevens CW
    Pharmacol Biochem Behav; 1984 Aug; 21(2):213-7. PubMed ID: 6333037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of kappa-opioid receptor ligands on intracranial self-stimulation in rats.
    Todtenkopf MS; Marcus JF; Portoghese PS; Carlezon WA
    Psychopharmacology (Berl); 2004 Apr; 172(4):463-70. PubMed ID: 14727002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphine differentially affects ventral tegmental and substantia nigra brain reward thresholds.
    Nazzaro JM; Seeger TF; Gardner EL
    Pharmacol Biochem Behav; 1981 Mar; 14(3):325-31. PubMed ID: 7232458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal administration of levorphanol or dextrorphan to the rat: analgesic effect of morphine in the offspring.
    O'Callaghan JP; Holtzman SG
    J Pharmacol Exp Ther; 1977 Feb; 200(2):255-62. PubMed ID: 14248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opiate antagonists and self-stimulation: extinction-like response patterns suggest selective reward deficit.
    Trujillo KA; Belluzzi JD; Stein L
    Brain Res; 1989 Jul; 492(1-2):15-28. PubMed ID: 2752295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.